LXEO
Lexeo Therapeutics, Inc.
3.30$
-2.4%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 100.0% | 99.9% | 82.5% | 88.9% | 85.8% | 70.1% | |
| 99.9% | 99.3% | 79.7% | 86.9% | 23.8% | 23.4% | |
| 99.9% | 99.3% | 79.7% | 86.9% | 82.7% | 67.6% | |
| 118.8% | 140.6% | 216.4% | 18.8% | 20.5% | 8.2% | |
| 2.4% | 5.4% | 14.8% | 12.3% | 15.5% | 6.3% | |
| 1.7% | 3.2% | 2.9% | 1.9% | 1.8% | 1.0% | |
| 0.2% | 2.2% | 2.8% | 2.7% | 4.4% | 1.8% | |
| -18.8% | -40.6% | -116.4% | 81.2% | 79.5% | 91.8% | |
| -18.9% | -41.0% | -118.9% | -130.1% | -190.7% | -141.5% | |
| 85.6% | 18.4% | 25.9% | 19.1% | 21.6% | 20.0% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.